Global CRO footprint OPIS operates as a global clinical CRO with affiliates in 18 countries, offering end-to-end trial support from concept to closure. This indicates potential for multinational trial collaboration and expansion opportunities across regions where OPIS has a presence.

Therapeutic breadth With experience across oncology, cardiology, dermatology, neurology and more, including rare diseases and vaccines, OPIS can address diverse sponsor needs and be a versatile partner for studying multiple therapeutic areas or expanding into new indications.

Full-service capacity OPIS provides 360° clinical trial services, from protocol development to data handling and reporting, plus medical device and nutraceutical studies, signaling opportunities to upsell integrated services or hybrids (drug-device combinations, post-marketing investigations).

Track record and scale Access to a 26-year track record with over 1500 studies and a mid-market size (201–500 employees) positions OPIS as a capable yet agile partner for mid-to-large sponsors seeking reliable execution without the overhead of a mega-CRO.

Security and compliance Recent emphasis on data protection partnerships and digital security, along with ISO and other standard tooling, highlights an angle for sponsors prioritizing rigorous compliance, data integrity, and risk management in global trials.